Annual report pursuant to Section 13 and 15(d)

NET LOSS PER SHARE (Tables)

v3.19.1
NET LOSS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Schedule of anti-dilutive

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows: 

 

    Year ended
December 31, 2018
(Shares)
    Year ended
December 31, 2017
(Shares)
 
             
Convertible debt     77,911,950       18,884,635  
Stock options     2,000,000          
Warrants to purchase shares of common stock     8,527,713       8,527,713  
      88,439,663       27,412,348